Accidental intrathecal administration of vincristine.

Vincristine is a chemotherapeutic agent used in the treatment of various neoplastic diseases. Its neurotoxicity after therapeutic and pharmacologic doses has been well documented. We report a case of accidental intrathecal administration of vincristine in order to describe the complications seen, discuss possible means of therapeutic intervention, and serve as a reminder that preventive measures are mandatory to avoid such accidents in the future.

[1]  H. Wiśniewski,et al.  EFFECTS OF MITOTIC SPINDLE INHIBITORS ON NEUROTUBULES AND NEUROFILAMENTS IN ANTERIOR HORN CELLS , 1968, The Journal of cell biology.

[2]  I. S. Johnson,et al.  THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS. , 1963, Cancer research.

[3]  F. Kung,et al.  Overdosage with vincristine. , 1976, The Journal of pediatrics.

[4]  P. Lampert,et al.  NEURONAL CHANGES INDUCED BY INTRATHECAL VINCRISTINE SULFATE , 1968, Journal of neuropathology and experimental neurology.

[5]  V. Oliverio,et al.  The pharmacokinetics of [3H]‐vincristine in man , 1977, Clinical pharmacology and therapeutics.